Gianluca Carrera

Data monetisation deals register

Where the value actually went.

Data licensing agreements, partnerships, acquisitions and other announced data monetisation moves, each read from the data owner’s seat: who did the work, what crossed, and who kept the rake.

347 deals tracked · 45 published analyses · updated

Entries are classified by a stated method — including the ones where the public facts do not settle it, which are published as unclear rather than guessed.

Deals tracked: 347

  • Health & life sciences 88
  • Financial services 50
  • Retail & consumer 27
  • Media & publishing 84
  • Advertising & marketing 21
  • Technology & AI 23
  • Telecom 4
  • Real estate 14
  • Mobility & automotive 10
  • Public sector & non-profit 2
  • Other 24

Every data deal I find is checked against its sources and kept on my record. The ones I have analysed in full are published below. How I track deals

RSS

14 entriessell 10unclear 2n/a 2
AnnouncedDealRouteConfiguration
2026-10-23Tempus licenses neurological patient dataset to Pathos AI in five-year agreementTempus AI · Pathos AISellBuyer-enriched
2026-10-07Biohub, DOE, NIH, Google DeepMind, Isomorphic Labs and Meta expand biological data collaborationChan Zuckerberg Biohub · U.S. Department of Energy · National Institutes of Health · Google DeepMindN/ANot relevant
2026-09-15Neuberger and KKR agree significant minority stake in health-data platform Datavant alongside New MountainDatavant · Neuberger · KKR · New Mountain CapitalN/AOwner-enriched
2026-09-11Owkin licenses K Pro AI scientist and MOSAIC multimodal patient data to Servier for oncology researchOwkin · ServierSellOwner-enriched
2026-09-11reportedMitsui signs service agreement with Oncoshot to analyse IHH oncology real-world data across Asia-PacificMitsui & Co. · Oncoshot · IHH HealthcareSellPartner-enriched, owner-fronted
2026-09-09Flatiron Health renews NCCN real-world oncology data collaboration through 2028, deploys Flatiron TelescopeFlatiron Health · National Comprehensive Cancer NetworkUnclearOwner-enriched
2026-09-02date uncertainnference and Rush University System for Health announce long-term partnership for Rush-hosted clinical analytics platformnference · Rush University System for HealthUnclearPartner-enriched, owner-fronted
2026-09-02Owkin licenses K Pro AI Scientist plus multimodal oncology and immunology patient data to Boehringer IngelheimOwkin · Boehringer IngelheimSellOwner-enriched
2026-08-14Thermo Fisher partners with HealthVerity for enterprise access to real-world claims datasetThermo Fisher Scientific · HealthVeritySellOwner-enriched
2026-07-28OneMedNet signs $11.5M+ agreement to supply regulatory-grade real-world imaging data for foundational AI model trainingOneMedNetSellBuyer-enriched
2026-04-09date uncertainTempus AI expands multi-year collaboration giving Gilead enterprise-wide access to Lens platform and multimodal real-world oncology dataTempus AI · Gilead SciencesSellOwner-enriched
2026-04-02TriNetX licenses access to data on about 300 million patients to Regeneron for drug discoveryTriNetX · Regeneron PharmaceuticalsSellBuyer-enriched
2026-04-01reportedAnthropic's $400M acquisition of Coefficient Bio for domain-specific biotech data underscores substrate dimensionsAnthropic · Coefficient Bio · DimensionSellUnclear
2026-03-03Tempus expands multi-year Merck collaboration giving Merck access to de-identified multimodal data and Lens platformTempus AI · MerckSellOwner-enriched

Newsletter

Each essay, by email, as it is published.

For operators, boards and investors who have to decide where value goes before the dust settles.

Delivered by Substack: you confirm on the next page.